While victims of intimate partner violence (IPV) have increased risk of chronic disease, little is known about their preventive screening behaviors. The objective of this study was to relate IPV to health status, chronic disease, and preventive screening behaviors. We hypothesized that women who reported poorer health statuses, higher rates of HIV, no primary care, and less-frequent HIV testing, breast exams, and Pap smears would be more likely to experience IPV. Adult females who presented to three Emergency Departments (EDs) on weekdays from 11:00 a.m. to 7:00 p.m. over a 14-month period were asked to participate in a computerized survey. Women were excluded if they were critically ill, did not speak English, intoxicated, or psychotic. Validated measures were used, including the Universal Violence Prevention Screen and the Short Form-12. Patients were asked about their health statuses, HIV statuses, and testing, if they had a regular doctor, and how often they had received pap smears and breast exams. Logistic regression modeling was used to test associations between IPV and the predictor variables, adjusting for age, employment, and education. Out of 3,381 approached, 1,474 women (43.6%) agreed to be surveyed. Age averaged 39 years ± 12.3 (range = 18-65), and most participants were Black (n = 722, 86.8%). One hundred and fifty-three out of 832 women (18.4%) who had been in a relationship the previous year had experienced IPV. Compared with HIV-negative women, those with HIV were 5 times more likely to suffer IPV (adjusted odds ratio [AOR] = 5.113, p = .001), and women who were not sure of their HIV status were 9 times more likely to experience IPV (AOR = 8.818, p < .001). Women who performed monthly self-breast exams were 53% less likely to experience IPV as those who rarely examined themselves (AOR = 0.470, p = .010). Women who have HIV or are unsure of their status and those who rarely perform self-breast exams are at increased risk of IPV.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0886260513497312 | DOI Listing |
Dig Dis Sci
January 2025
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Background: Chronic constipation, diarrhea, and fecal incontinence (FI) are prevalent with significant impact on quality of life and healthcare utilization. Thyroid dysfunction was recognized as a potential contributor to bowel disturbances in selected populations, but the strength/consistency of this association remain unclear.
Aims: To investigate the relationship between thyroid function and bowel health measures (constipation, diarrhea, and FI) in a nationally representative sample of the U.
Metab Brain Dis
January 2025
Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 2752, Porto Alegre, CEP 90610-000, RS, Brazil.
Phenylketonuria is a genetic disorder characterized by high phenylalanine levels, the main toxic metabolite of the disease. Hyperphenylalaninemia can cause neurological impairment. In order to avoid this symptomatology, patients typically follow a phenylalanine-free diet supplemented with a synthetic formula that provides essential amino acids, including L-carnitine.
View Article and Find Full Text PDFClin Rheumatol
January 2025
Department of Rheumatology, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
Introduction/objectives: Sjogren's syndrome (SS) is a chronic inflammatory and difficult-to-treat autoimmune disease. Timosaponin AIII (TAIII), a plant-derived steroidal saponin, effectively inhibits cell proliferation, induces apoptosis, and exhibits anti-inflammatory properties. This study explored the mechanisms of action of TAIII in SS treatment by studying gut microbiota and short-chain fatty acids (SCFAs) using fecal metabolomics.
View Article and Find Full Text PDFCurr Cardiol Rep
January 2025
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Purpose Of Review: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, characterized by hepatic steatosis with at least one cardiometabolic risk factor. Patients with MASLD are at increased risk for the occurrence of cardiovascular events. Within this review article, we aimed to provide an update on the pathophysiology of MASLD, its interplay with cardiovascular disease, and current treatment strategies.
View Article and Find Full Text PDFClin Exp Nephrol
January 2025
Department of Nephrology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Background: Previous studies have suggested a potential role of estrogen in the pathophysiology of chronic kidney disease (CKD); however, the association and causality between estrogen and kidney function remain unclear.
Methods: The cross-sectional correlation between serum estradiol concentration and estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR) was analyzed using data from the National Health and Nutrition Examination Survey 2013-2016. Causality was tested using mutual bidirectional Mendelian randomization (MR) approaches based on six large-scale GWAS studies.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!